RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
platelet abnormality characterized by defective clot formation, impaired aggregation, and prolonged bleeding time; other manifestations include nosebleeds, inappropriate bruising, and excessive bleeding.
View Complete Description|
|
|
||
|---|---|---|---|
| ITGA2B |
100
|
||
| ITGB3 |
99
|
Individual Studies |
|
|---|---|
|
|
Authors: Lena Svensson, Kimberley Howarth, Alison McDowall, Irene Patzak, Rachel Evans, Siegfried Ussar, Markus Moser, Ayse Metin, Mike Fried, Ian Tomlinson,…
Nature medicine 2009 MarAuthors: Vincent Jallu, Mathilde Dusseaux, Simon Panzer, Marie-Françoise Torchet, Nathalie Hezard, Jenny Goudemand, Alexandre G de Brevern, Cécile Kaplan
Human mutation 2010 MarThought leaders and organizations working on research involving Glanzmann's thrombasthenia.
conditions: Glanzmann Thrombasthenia
interventions: none
conditions: Haemophilia
interventions: activated recombinant human factor VII
Postdoctoral fellow
U.S.FDA
No NextBio groups were found for “Glanzmann's thrombasthenia”.
Be the first to
start
a group and share your interests with others within the NextBio community.